Cameron Budenz, MD
Otology & Neurotology · Tarrytown, NYNPI 1679609465
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 163 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations.
Across 163 payments — averaging $21.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$617
- CSL Behring$296
- Pharming Healthcare, Inc.$280
- Sanofi$267
- Takeda Pharmaceuticals U.S.A., Inc.$253
- Novartis$242
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,485100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 31 | $617 |
| CSL Behring | 11 | $296 |
| Pharming Healthcare, Inc. | 14 | $280 |
| Sanofi | 13 | $267 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $253 |
| Novartis | 12 | $242 |
| GSK | 14 | $230 |
| Cochlear Americas | 2 | $146 |
| AstraZeneca | 5 | $97 |
| Biocryst US Sales Co., LLC | 5 | $96 |
| Regeneron Healthcare Solutions, Inc. | 6 | $92 |
| Hikma Pharmaceuticals USA | 4 | $77 |
| Stryker | 3 | $75 |
| Kaleo, Inc. | 4 | $72 |
| Neurent Medical Limited | 2 | $54 |
| Genentech USA, Inc. | 2 | $51 |
| Integra Lifesciences Corporation | 1 | $46 |
| Medtronic | 2 | $45 |
| Smith+Nephew | 2 | $44 |
| Acclarent, Inc | 1 | $44 |
| Pfizer | 2 | $40 |
| Alk-abello, Inc | 2 | $39 |
| Precigen, Inc. | 1 | $34 |
| Incyte Corporation | 1 | $28 |
| Ionis Pharmaceuticals, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Bio Products Laboratory USA, Inc. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Shire North American Group Inc | 1 | $20 |
| Cook Medical LLC | 1 | $17 |
| Med-el Corporation | 1 | $16 |
| Merck | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Glenmark Therapeutics Inc. | 1 | $12 |
How this compares
$3,485 in reported general payments places this provider in the 55th percentile of 26 otology & neurotology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 54 | $6,222 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 37 | $3,122 |
| Prednisolone Acetate | 45 | $2,109 |
| Fluticasone Propionate | 48 | $768 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 50 | $511 |
| Clotrimazole | 16 | $391 |
| CefuroximeCefuroxime Axetil | 11 | $87 |
| Prednisone | 14 | $60 |
Paid to pharmacies, not to this prescriber.
Other otology & neurotology in Tarrytown
- John RolandNew York$86K
- Sean McMenomeyNew York$27K
- Daniel JethanamestNew York$17K
- Zachary SchwamNew York$15K
- Raymond PaoliniWilliamsville$12K
- David FriedmannNew York$11K
- Katrina StidhamHawthorne$10K
- George AlexiadesNew York$8K
- Sujana ChandrasekharNew York$5K
- Eric SmouhaNew York$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.